It takes more than a vaccine to make a successful immunization program. This World Immunization Week, we are taking a look at some of the factors that contribute to effective immunization programs.

International efforts to improve dengue communication and advocacy have increased over the last years, as dengue becomes one of the fastest spreading vector-borne diseases.

Dr. Sazaly has been involved with dengue research for over 20 years and has also maintained strong research interest in emerging infectious diseases. His interest in dengue, in particular, is rooted in its knowledge gaps: “it is a fascinating disease needing a lot more research to take on.” In an interview with DVI, Dr. Sazaly shares more on his views of dengue prevention and control and needs in the dengue research field.

Image: Child undergoing scan at Dengue High Dependency Unit Negombo General Hospital 

Every three months, the Dengue Vaccine Initiative (DVI) highlights a “Dengue Champion,” calling attention to that person’s contribution to the dengue vaccine research field and their commitment to the fight against dengue fever. Dr.

by Dr. Giovanini Coelho 

Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate.

This blog was originally posed on the Dengue Vaccine Initiative website
 
This year’s Americas Dengue Prevention Board (DPB)

Pages